Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Vanessa Andrés-Guerrero
Lucía Perucho-González
Julián García-Feijoo
Laura Morales-Fernández
Federico Saenz-Francés
Rocío Herrero-Vanrell
Luis Pablo Júlvez
Vicente Polo Llorens
José María Martínez-de-la-Casa
Anastasios-Georgios P. Konstas
10.6084/m9.figshare.6411197.v1
https://adisjournals.figshare.com/articles/online_resource/Current_Perspectives_on_the_Use_of_Anti-VEGF_Drugs_as_Adjuvant_Therapy_in_Glaucoma/6411197
<p><strong>Article full
text</strong></p>
<br>
The
full text of this article can be found <a href="https://link.springer.com/article/10.1007/s12325-016-0461-z"><b>here</b>.</a><br>
<br>
<strong>Provide enhanced digital features for this article</strong><br>
If you are an author of this publication and would like to provide additional
enhanced digital features for your article then please contact <u>adisrapidplus@springer.com</u>.<br>
<br>
The journal offers a range of additional features designed to increase
visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as ‘peer reviewed’ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.<br>
<br>
Other enhanced features include, but are
not limited to:<br>
• Slide decks<br>
• Videos and animations<br>
• Audio abstracts<br>
• Audio slides
2018-06-03 20:46:17
Angiogenesis
Aflibercept
Bevacizumab
Glaucoma filtration surgery
Neovascular glaucoma
Ranibizumab
VEGF
Wound modulation